author-photo

Craig Innes

Fred Hutchinson Cancer Research Center

9

Papers

232

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial

2018 The Lancet HIV
Show All
- Source
- Cite
- Save
Citations (59)
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial

2016 Annals of Internal Medicine
Show All
- Source
- Cite
- Save
Citations (57)
Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.

2015 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (19)
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

2014 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (87)
Uptake of genital mucosal sampling in HVTN 097, a phase 1b HIV vaccine trial in South Africa

2014 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (6)
The phase 2b HVTN 503/Phambili study test-of-concept HIV vaccine study, investigating a recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up

2014 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (1)